Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EMA recommends new orphan designation for 4SC-201

Oct. 13, 2011

Bayer and Onyx Pharmaceuticals restructure oncology collaboration

Oct. 13, 2011

FDA issues warning regarding leukemia drug Sprycel

Oct. 13, 2011

GSK provides funding for cancer research program

Oct. 13, 2011

Preclinical data support first-in-human trial of NBTXR-3

Oct. 13, 2011

Cellceutix adds new indication to IND application for Kevetrin

Oct. 11, 2011

Adherex to discuss development of sodium thiosulfate with FDA advisory committee

Oct. 10, 2011

BAY-1017858 shows promise in vitro and in vivo

Oct. 10, 2011

AXL-1717 benefits patients with advanced-stage NSCLC in phase I trial

Oct. 10, 2011

Millennium withdraws sNDA for Velcade

Oct. 7, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.